UnknownNCT06493071
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Inflammation and Depression Following SCI
Device studyAges 18+Canada
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.
- Listed locations
- LondonSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 27, 2025
- Recruitment status
- Unknown
- Enrollment listed in the registry
- 44
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Sponsor type
- Research institute
- Study type
- Device
- Intervention type
- Device
- Locations
- Canada
- Age range
- Over 18 Years
- Official registry ID
- NCT06493071
- Official title
Show the full official title
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) as an Anti-inflammatory Strategy for the Treatment of Depression Following Spinal Cord Injury
Recruitment & locations
Status unknownThis badge reflects the study status reported by the registry. Check the registry for the latest information.
London
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, a research institute.
Who can participate?
This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.
